LivaNova Plc (LIVN)
63.97
-0.66
(-1.02%)
USD |
NASDAQ |
Apr 02, 14:43
LivaNova Research and Development Expense (TTM) : 185.14M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| NovoCure Ltd. | 224.54M |
| Intuitive Surgical, Inc. | 1.312B |
| Tandem Diabetes Care, Inc. | 192.28M |
| Abbott Laboratories | 2.89B |
| Plus Therapeutics, Inc. | 8.379M |